As depicted in Figures 1and2 there was a greater than 10-fold difference in IC50s between sensitive and resistant CRC cell lines that did not correlate with mutational status of KRAS, BRAF, or PIK3CA. This evidence concerns the gene BRAF and colorectal carcinoma.